Back
Assembly Biosciences Vs. Protagonist Therapeutics Industry Stock Comparison
Sell
42
ASMB
Assembly Biosciences
Last Price:
14.99
Seasonality Move:
15.76%
Sell
45
PTGX
Protagonist Therapeutics
Last Price:
46.45
Seasonality Move:
11.46%
Sell
42
Assembly Biosciences (ASMB)
is a Sell
Is Assembly Biosciences a Buy, Sell or Hold?
- The current Assembly Biosciences [ASMB] share price is $15.04. The Score for ASMB is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- ASMB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $46.46. The Score for PTGX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ASMB Stock Price Chart
What is Assembly Biosciences's stock price today?
-
The Assembly Biosciences share price today is $15.04
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASMB is experiencing buying pressure, which is a positive indicator for future bullish movement.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $46.46
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing buying pressure, which is a positive indicator for future bullish movement.
ASMB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.39 | Sell |
Relative Strength Index (14 RSI): | 39.13 | Sell |
Chaikin Money Flow: | 16233 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.73 - 17.25) | Sell |
Bollinger Bands (100): | (14.21 - 17.17) | Sell |
PTGX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.01 | Sell |
Relative Strength Index (14 RSI): | 57.05 | Buy |
Chaikin Money Flow: | 782176 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (42.22 - 47.9) | Buy |
Bollinger Bands (100): | (38.27 - 46.31) | Buy |
ASMB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.71 | Sell |
20-day SMA: | 16.42 | Sell |
50-day SMA: | 16.5 | Sell |
200-day SMA: | 14.65 | Buy |
8-day EMA: | 15.54 | Sell |
20-day EMA: | 16.1 | Sell |
50-day EMA: | 16.21 | Sell |
200-day EMA: | 14.87 | Buy |
PTGX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.58 | Buy |
20-day SMA: | 44.66 | Buy |
50-day SMA: | 45.25 | Buy |
200-day SMA: | 35.78 | Buy |
8-day EMA: | 42.72 | Buy |
20-day EMA: | 43.78 | Buy |
50-day EMA: | 44.02 | Buy |
200-day EMA: | 36.88 | Buy |
Assembly Biosciences Earnings Growth & ASMB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.35 per share, and a decrease next year of $1.16 per share.
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.45 per share, and a decrease next year of $3.44 per share.
Assembly Biosciences Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Protagonist Therapeutics Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |